Enhabit Share Holder Equity 2020-2023 | EHAB
Enhabit share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
| Enhabit Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $697 |
| 2022 | $770 |
| 2021 | $1,478 |
| 2020 | $1,390 |
| 2019 | $0 |
| Enhabit Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $697 |
| 2023-09-30 | $704 |
| 2023-06-30 | $702 |
| 2023-03-31 | $771 |
| 2022-12-31 | $770 |
| 2022-09-30 | $864 |
| 2022-06-30 | $851 |
| 2022-03-31 | $1,496 |
| 2021-12-31 | $1,478 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $1,390 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.511B | $1.046B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.475B | 15.37 |
| Cencora (COR) | United States | $44.674B | 17.41 |
| ICON (ICLR) | Ireland | $25.493B | 24.07 |
| DiDi Global (DIDIY) | China | $24.448B | 0.00 |
| Avantor (AVTR) | United States | $16.791B | 24.72 |
| Viatris (VTRS) | United States | $14.026B | 4.03 |
| CochLear (CHEOY) | Australia | $13.917B | 0.00 |
| Revvity (RVTY) | United States | $12.428B | 21.78 |
| Medpace Holdings (MEDP) | United States | $12.163B | 40.02 |
| Charles River Laboratories (CRL) | United States | $12.026B | 21.92 |
| Natera (NTRA) | United States | $11.711B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.540B | 0.00 |
| Solventum (SOLV) | United States | $11.153B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
| HealthEquity (HQY) | United States | $6.740B | 50.35 |
| Organon (OGN) | United States | $5.043B | 4.78 |
| Bausch + Lomb (BLCO) | Canada | $4.779B | 19.16 |
| Doximity (DOCS) | United States | $4.494B | 33.46 |
| PACS (PACS) | United States | $3.725B | 0.00 |
| Sotera Health (SHC) | United States | $3.119B | 15.31 |
| Surgery Partners (SGRY) | United States | $3.118B | 28.86 |
| Progyny (PGNY) | United States | $3.049B | 51.16 |
| GoodRx Holdings (GDRX) | United States | $2.804B | 142.00 |
| Life Times (LTH) | United States | $2.783B | 29.48 |
| Premier (PINC) | United States | $2.460B | 9.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.256B | 7.30 |
| Teladoc Health (TDOC) | United States | $2.167B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.970B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.590B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.451B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Alignment Healthcare (ALHC) | United States | $1.268B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.784B | 8.11 |
| Embecta (EMBC) | United States | $0.584B | 3.86 |
| InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.514B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| CareDx (CDNA) | United States | $0.503B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| MultiPlan (MPLN) | United States | $0.422B | 0.00 |
| Beauty Health (SKIN) | United States | $0.415B | 0.00 |
| ModivCare (MODV) | United States | $0.383B | 7.18 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| Sera Prognostics (SERA) | United States | $0.352B | 0.00 |
| Sharecare (SHCR) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.161B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.080B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |